芍药内酯苷对人卵巢癌多药耐药的逆转作用  被引量:2

The reversal effect of albiflorin on multidrug resistance of human ovarian cancer and its mechanism

在线阅读下载全文

作  者:韩立 郭晓娟[1] 杜瑞娟 陈怡 费庆林[1] 郭克磊 卞华 HAN Li;GUO Xiao-juan;DU Rui-juan;CHEN Yi;FEI Qing-lin;GUO Ke-lei;BIAN Hua(ZHANG Zhong-jing School of Chinese Medicine,Nanyang Institute of Technology,Nanyang,Henan 473004,China;Henan Key Laboratory of ZHANG Zhong-jing Formulae and Herbs for Immunoregulation,Nanyang Institute of Technology,Nanyang,Henan 473004,China)

机构地区:[1]南阳理工学院张仲景国医国药学院 [2]南阳理工学院,河南省张仲景方药与免疫调节重点实验室,河南南阳473004

出  处:《中国药理学通报》2023年第2期268-274,共7页Chinese Pharmacological Bulletin

基  金:国家自然科学基金面上项目(No 82074076);河南省自然科学基金面上项目(No 202300410022)

摘  要:目的研究芍药内酯苷(albiflorin,AL)逆转人卵巢癌多药耐药的作用和潜在机制。方法采用CCK-8试剂盒检测AL对SKOV3/DDP细胞的耐药逆转作用,采用流式细胞术检测AL对P糖蛋白(P-glycoprotein,P-gp)功能的影响,采用RT-qPCR和Western blot检测AL对SKOV3/DDP细胞中MYC、WWP1和ABCB1/P-gp的影响。采用RNA干扰技术构建MYC敲低的SKOV3/DDP细胞株,观察其耐药性、P-gp功能及相关基因和蛋白表达变化。结果AL对SKOV3/DDP细胞有耐药逆转作用,对P-gp功能抑制作用具有浓度依赖性。AL 25、50、100μmol·L^(-1)对ABCB1/P-gp、MYC和WWP1的抑制作用均逐渐增强。MYC抑制剂MYCi975对ABCB1/P-gp、MYC和WWP1的抑制作用均强于或相当于AL 100μmol·L^(-1)组。SKOV3/DDP细胞敲低MYC后,细胞耐药性、P-gp功能以及相关基因和蛋白表达均受到抑制。结论AL对SKOV3/DDP细胞的耐药逆转作用可能与抑制P-gp功能和ABCB1/P-gp、MYC、WWP1表达有关,为AL作为耐药逆转剂用于卵巢癌的临床治疗提供了实验基础。Aim To study the reversal effect of albiflorin(AL)on multidrug resistance of human ovarian cancer and the potential mechanism.Methods The drug resistance reversal effect of AL on SKOV3/DDP cells was detected by CCK-8 kit,and the effect of AL on P-glycoprotein(P-gp)function was detected by flow cytometry.The effects of AL on MYC,WWP1 and ABCB1 in SKOV3/DDP cells were detected by RT-qPCR and Western blot.The MYC-knockdown SKOV3/DDP cell line was constructed by RNA interference technology,and its drug resistance,P-gp function and related gene and protein expression changes were investigated.Results AL had a drug resistance reversal effect on SKOV3/DDP cells and a concentration-dependent inhibitory effect on P-gp function.The inhibitory effects of AL 25,50 and 100μmol·L^(-1) on ABCB1/P-gp,MYC and WWP1 were gradually enhanced.The inhibitory effect of MYCi975,a MYC inhibitor,on ABCB1/P-gp,MYC and WWP1 was stronger than or equivalent to that of AL 100μmol·L^(-1) group.After knockdown of MYC in SKOV3/DDP cells,cell drug resistance,P-gp function,and related gene and protein expression were inhibited.Conclusions The drug resistance reversal effect of AL on SKOV3/DDP cells may be related to the inhibition of P-gp function and the expression of ABCB1/P-gp,MYC and WWP1,which provides an experiment base for the development of AL as a drug resistance reversal agent for the clinical treatment of ovarian cancer.

关 键 词:卵巢癌 多药耐药 芍药内酯苷 MYC WW结构域E3泛素连接酶1 P糖蛋白 

分 类 号:R284.1[医药卫生—中药学] R341.32[医药卫生—中医学] R345R394.2R737.31

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象